Molecular Therapies for Viral Hepatitis

Author： Guha C.   Shah S.J.   Ghosh S.S.   Lee S.W.   Roy-Chowdhury N.   Roy-Chowdhury J.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.17, Iss.2, 2003-01, pp. : 81-91

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic burden of inpatients with viral hepatitis B-related diseases and the influencing factors

By  

Family Medicine and Community Health, Vol. 1, Iss. 4, 2013-01 ,pp. : 31-35

Compuscript

Access to resources Recommend Favorite

Viral hepatitis elimination should receive more attention from Iranian nurses

By  

Research In Nursing & Health, Vol. 41, Iss. 1, 2018-02 ,pp. : 9-10

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sunitinib: A Multitargeted Receptor Tyrosine Kinase Inhibitor in the Era of Molecular Cancer Therapies

By Papaetis Georgios S.   Syrigos Kostas N.  

BioDrugs, Vol. 23, Iss. 6, 2009-12 ,pp. : 377-389

Adis International

Access to resources Recommend Favorite

Interferon- -n1: A Review of its Pharmacological Properties and Therapeutic Efficacy in the Management of Chronic Viral Hepatitis

By Perry C.M.   Wagstaff A.J.  

BioDrugs, Vol. 9, Iss. 2, 1998-02 ,pp. : 125-154

Adis International

Access to resources Recommend Favorite

Therapies for all

By Wray Julie   Baston Helen  

The Practising Midwife, Vol. 15, Iss. 5, 2012-05 ,pp. : 4-4

Medical Education Solutions Limited

Access to resources Recommend Favorite